Global Cyclic Peptide Compounds Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Cyclic Peptide Compounds Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

According to APO Research, The global Cyclic Peptide Compounds market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Cyclic Peptide Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Cyclic Peptide Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Cyclic Peptide Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Cyclic Peptide Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Cyclic Peptide Compounds include Apellis Pharmaceuticals, Bachem, Bicycle Therapeutics, Merck, Roche (Chugai Pharmabody Research), Pfizer, Novartis and Biopharma PEG Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cyclic Peptide Compounds, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cyclic Peptide Compounds, also provides the sales of main regions and countries. Of the upcoming market potential for Cyclic Peptide Compounds, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cyclic Peptide Compounds sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Cyclic Peptide Compounds market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Cyclic Peptide Compounds sales, projected growth trends, production technology, application and end-user industry.

Cyclic Peptide Compounds segment by Company

Apellis Pharmaceuticals
Bachem
Bicycle Therapeutics
Merck
Roche (Chugai Pharmabody Research)
Pfizer
Novartis
Biopharma PEG Scientific

Cyclic Peptide Compounds segment by Type

Synthetic Cyclic Peptide
Natural Cyclic Peptide

Cyclic Peptide Compounds segment by Application

Biopharmaceutical
Scientific Research
Environmental Protection
Others

Cyclic Peptide Compounds segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Cyclic Peptide Compounds status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Cyclic Peptide Compounds market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cyclic Peptide Compounds significant trends, drivers, influence factors in global and regions.
6. To analyze Cyclic Peptide Compounds competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclic Peptide Compounds market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclic Peptide Compounds and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclic Peptide Compounds.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyclic Peptide Compounds market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyclic Peptide Compounds industry.
Chapter 3: Detailed analysis of Cyclic Peptide Compounds manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Cyclic Peptide Compounds in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Cyclic Peptide Compounds in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Cyclic Peptide Compounds Sales Value (2019-2030)
1.2.2 Global Cyclic Peptide Compounds Sales Volume (2019-2030)
1.2.3 Global Cyclic Peptide Compounds Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Cyclic Peptide Compounds Market Dynamics
2.1 Cyclic Peptide Compounds Industry Trends
2.2 Cyclic Peptide Compounds Industry Drivers
2.3 Cyclic Peptide Compounds Industry Opportunities and Challenges
2.4 Cyclic Peptide Compounds Industry Restraints
3 Cyclic Peptide Compounds Market by Company
3.1 Global Cyclic Peptide Compounds Company Revenue Ranking in 2023
3.2 Global Cyclic Peptide Compounds Revenue by Company (2019-2024)
3.3 Global Cyclic Peptide Compounds Sales Volume by Company (2019-2024)
3.4 Global Cyclic Peptide Compounds Average Price by Company (2019-2024)
3.5 Global Cyclic Peptide Compounds Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Cyclic Peptide Compounds Company Manufacturing Base & Headquarters
3.7 Global Cyclic Peptide Compounds Company, Product Type & Application
3.8 Global Cyclic Peptide Compounds Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Cyclic Peptide Compounds Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Cyclic Peptide Compounds Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Cyclic Peptide Compounds Market by Type
4.1 Cyclic Peptide Compounds Type Introduction
4.1.1 Synthetic Cyclic Peptide
4.1.2 Natural Cyclic Peptide
4.2 Global Cyclic Peptide Compounds Sales Volume by Type
4.2.1 Global Cyclic Peptide Compounds Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Cyclic Peptide Compounds Sales Volume by Type (2019-2030)
4.2.3 Global Cyclic Peptide Compounds Sales Volume Share by Type (2019-2030)
4.3 Global Cyclic Peptide Compounds Sales Value by Type
4.3.1 Global Cyclic Peptide Compounds Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Cyclic Peptide Compounds Sales Value by Type (2019-2030)
4.3.3 Global Cyclic Peptide Compounds Sales Value Share by Type (2019-2030)
5 Cyclic Peptide Compounds Market by Application
5.1 Cyclic Peptide Compounds Application Introduction
5.1.1 Biopharmaceutical
5.1.2 Scientific Research
5.1.3 Environmental Protection
5.1.4 Others
5.2 Global Cyclic Peptide Compounds Sales Volume by Application
5.2.1 Global Cyclic Peptide Compounds Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Cyclic Peptide Compounds Sales Volume by Application (2019-2030)
5.2.3 Global Cyclic Peptide Compounds Sales Volume Share by Application (2019-2030)
5.3 Global Cyclic Peptide Compounds Sales Value by Application
5.3.1 Global Cyclic Peptide Compounds Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Cyclic Peptide Compounds Sales Value by Application (2019-2030)
5.3.3 Global Cyclic Peptide Compounds Sales Value Share by Application (2019-2030)
6 Cyclic Peptide Compounds Market by Region
6.1 Global Cyclic Peptide Compounds Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Cyclic Peptide Compounds Sales by Region (2019-2030)
6.2.1 Global Cyclic Peptide Compounds Sales by Region: 2019-2024
6.2.2 Global Cyclic Peptide Compounds Sales by Region (2025-2030)
6.3 Global Cyclic Peptide Compounds Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Cyclic Peptide Compounds Sales Value by Region (2019-2030)
6.4.1 Global Cyclic Peptide Compounds Sales Value by Region: 2019-2024
6.4.2 Global Cyclic Peptide Compounds Sales Value by Region (2025-2030)
6.5 Global Cyclic Peptide Compounds Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Cyclic Peptide Compounds Sales Value (2019-2030)
6.6.2 North America Cyclic Peptide Compounds Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Cyclic Peptide Compounds Sales Value (2019-2030)
6.7.2 Europe Cyclic Peptide Compounds Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Cyclic Peptide Compounds Sales Value (2019-2030)
6.8.2 Asia-Pacific Cyclic Peptide Compounds Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Cyclic Peptide Compounds Sales Value (2019-2030)
6.9.2 Latin America Cyclic Peptide Compounds Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Cyclic Peptide Compounds Sales Value (2019-2030)
6.10.2 Middle East & Africa Cyclic Peptide Compounds Sales Value Share by Country, 2023 VS 2030
7 Cyclic Peptide Compounds Market by Country
7.1 Global Cyclic Peptide Compounds Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Cyclic Peptide Compounds Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Cyclic Peptide Compounds Sales by Country (2019-2030)
7.3.1 Global Cyclic Peptide Compounds Sales by Country (2019-2024)
7.3.2 Global Cyclic Peptide Compounds Sales by Country (2025-2030)
7.4 Global Cyclic Peptide Compounds Sales Value by Country (2019-2030)
7.4.1 Global Cyclic Peptide Compounds Sales Value by Country (2019-2024)
7.4.2 Global Cyclic Peptide Compounds Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.5.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.6.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.7.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.8.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.9.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.10.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.11.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.12.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.13.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.14.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.15.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.16.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.17.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.18.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.19.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.20.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.21.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.22.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Cyclic Peptide Compounds Sales Value Growth Rate (2019-2030)
7.23.2 Global Cyclic Peptide Compounds Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Cyclic Peptide Compounds Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Apellis Pharmaceuticals
8.1.1 Apellis Pharmaceuticals Comapny Information
8.1.2 Apellis Pharmaceuticals Business Overview
8.1.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Sales, Value and Gross Margin (2019-2024)
8.1.4 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolio
8.1.5 Apellis Pharmaceuticals Recent Developments
8.2 Bachem
8.2.1 Bachem Comapny Information
8.2.2 Bachem Business Overview
8.2.3 Bachem Cyclic Peptide Compounds Sales, Value and Gross Margin (2019-2024)
8.2.4 Bachem Cyclic Peptide Compounds Product Portfolio
8.2.5 Bachem Recent Developments
8.3 Bicycle Therapeutics
8.3.1 Bicycle Therapeutics Comapny Information
8.3.2 Bicycle Therapeutics Business Overview
8.3.3 Bicycle Therapeutics Cyclic Peptide Compounds Sales, Value and Gross Margin (2019-2024)
8.3.4 Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolio
8.3.5 Bicycle Therapeutics Recent Developments
8.4 Merck
8.4.1 Merck Comapny Information
8.4.2 Merck Business Overview
8.4.3 Merck Cyclic Peptide Compounds Sales, Value and Gross Margin (2019-2024)
8.4.4 Merck Cyclic Peptide Compounds Product Portfolio
8.4.5 Merck Recent Developments
8.5 Roche (Chugai Pharmabody Research)
8.5.1 Roche (Chugai Pharmabody Research) Comapny Information
8.5.2 Roche (Chugai Pharmabody Research) Business Overview
8.5.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales, Value and Gross Margin (2019-2024)
8.5.4 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolio
8.5.5 Roche (Chugai Pharmabody Research) Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Cyclic Peptide Compounds Sales, Value and Gross Margin (2019-2024)
8.6.4 Pfizer Cyclic Peptide Compounds Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 Novartis
8.7.1 Novartis Comapny Information
8.7.2 Novartis Business Overview
8.7.3 Novartis Cyclic Peptide Compounds Sales, Value and Gross Margin (2019-2024)
8.7.4 Novartis Cyclic Peptide Compounds Product Portfolio
8.7.5 Novartis Recent Developments
8.8 Biopharma PEG Scientific
8.8.1 Biopharma PEG Scientific Comapny Information
8.8.2 Biopharma PEG Scientific Business Overview
8.8.3 Biopharma PEG Scientific Cyclic Peptide Compounds Sales, Value and Gross Margin (2019-2024)
8.8.4 Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolio
8.8.5 Biopharma PEG Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Cyclic Peptide Compounds Value Chain Analysis
9.1.1 Cyclic Peptide Compounds Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Cyclic Peptide Compounds Sales Mode & Process
9.2 Cyclic Peptide Compounds Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Cyclic Peptide Compounds Distributors
9.2.3 Cyclic Peptide Compounds Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings